Founded in 2019, Claris Ventures focuses on investing in high potential life science and biotechnology companies arising from the Italian R&D ecosystem. The firm provides equity investments to biopharma companies with a clear vision and solid scientific evidence, with a focus on addressing strong unmet clinical needs in areas such as rare diseases, oncology, immunology, and other life-threatening diseases. Claris Ventures offers capital, competence, and hands-on support to jumpstart clinical development programs and pursue value creation based on clinical evidence.